In an effort to extend its runway into 2027, California’s Bolt Biotherapeutics will let go of 50% of its employees. Around 20 workers will be affected, according to an SEC document, with the layoffs expected to be complete by the end of the year.
In an effort to extend its runway into 2027, California’s Bolt Biotherapeutics will let go of 50% of its employees. Around 20 workers will be affected, according to an SEC document, with the layoffs expected to be complete by the end of the year.